AJCN 19th International Congress of Nutrition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rapuri, P. B
Right arrow Articles by Ryschon, K. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rapuri, P. B
Right arrow Articles by Ryschon, K. L
Agricola
Right arrow Articles by Rapuri, P. B
Right arrow Articles by Ryschon, K. L
American Journal of Clinical Nutrition, Vol. 72, No. 5, 1206-1213, November 2000
© 2000 American Society for Clinical Nutrition

Original Research Communication

Alcohol intake and bone metabolism in elderly women1,2,3,4

Prema B Rapuri, J Christopher Gallagher, Kurt E Balhorn and Kay L Ryschon

1 From the Bone Metabolism Unit and the Cardiac Center, Creighton University, School of Medicine, Omaha.

See corresponding editorial on page 1073.

2 Presented as an abstract at the 21st Annual Meeting of the American Society for Bone and Mineral Research, St Louis, MO, 30 September to 4 October 1999.

3 Supported by NIH grants UO1-AG10373 and RO1-AG10358.

4 Address reprint requests to PB Rapuri, Bone Metabolism Unit, Creighton University, School of Medicine, 601 North 30th Street, Room 6718, Omaha, NE 68131. E-mail: thiyyari{at}creighton.edu.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Published reports on the effect of alcohol consumption on bone mineral density (BMD) are inconsistent.

Objective: The objective of this study was to examine the relation between alcohol intake and BMD, calcitropic hormones, calcium absorption, and other biochemical indexes of bone and mineral metabolism in elderly women.

Design: The results presented are derived from baseline observations of 489 elderly women (aged 65–77 y) recruited for an osteoporosis study. The nondrinking group comprised 297 women and the drinking group comprised 148 women. Furthermore, the effect of different alcohol intakes (<=28.6, >28.6 to <=57.2, >57.2 to <=142.9, and >142.9 g/wk) was studied.

Results: Women who consumed alcohol had significantly higher spine (10%), total body (4.5%), and midradius (6%) BMD than did nondrinkers. An alcohol intake >28.6 g/wk was associated with higher BMD; maximum effect was seen with an intake of >28.6 to <=57.2 g/wk (16%, 12%, and 14% increase in spine, total body, and midradius BMD, respectively). There was a marked reduction in bone remodeling markers, serum osteocalcin, and the ratio of urinary cross-linked N-telopeptides of type 1 collagen to creatinine with alcohol consumption, suggesting that increased BMD with alcohol consumption could be due to reduced bone remodeling. Further, serum parathyroid hormone concentrations were significantly lower in alcohol drinkers than in nondrinkers and could be one of the causes of decreased bone resorption.

Conclusions: Moderate alcohol intake was associated with higher BMD in postmenopausal elderly women. The protective effect of alcohol may have been a result of lower bone remodeling due to reduced parathyroid hormone concentrations or factors such as increased estrogen concentrations.

Key Words: Alcohol • bone mineral density • BMD • bone remodeling • serum parathyroid hormone • elderly women


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Osteoporosis is a major public health problem in the elderly population of Western countries, affecting mostly women. It is the most important underlying cause of spine and hip fractures in elderly men and women. Of the various multiple risk factors, nutritional and lifestyle factors are recognized as important in the etiology of osteoporosis. Since the initial work of Saville (1, 2), alcohol consumption has been known to be a significant contributing factor to osteoporosis and osteoporotic fractures.

Several studies showed that chronic alcoholism leads to osteopenia and increased incidence of skeletal fractures (3–5). Studies carried out to understand the underlying mechanism suggested that alcohol may have a direct effect on bone cells and an indirect or modulatory effect through mineral regulatory hormones (6, 7). Alcohol has been shown to decrease the bone formation rate by decreasing the osteoblast number, osteiod formation, and osteoblast proliferation (8–10). However, the effect of alcohol consumption on bone resorption has not been established clearly. Some histomorphometric studies showed increased bone resorption in moderate and heavy drinkers (10), whereas others found no effect (11). In addition, calcitropic hormones, including serum parathyroid hormone (PTH) and vitamin D metabolites, were reported to be altered by alcohol consumption (12, 13).

There are conflicting reports in the literature regarding the effect of moderate alcohol consumption on bone. Some researchers did not find a positive association between moderate alcohol intake and bone mineral density (BMD) (14–21). However, recent studies, mostly in postmenopausal women, showed a positive correlation between BMD and moderate alcohol consumption (22–28). Holbrook and Barrett-Connor (26) reported that social drinking is associated with higher BMD in both men and women. Similar observations were made in a study by Felson et al (27), who found that elderly women with an alcohol intake of >=210 mL (7 oz)/wk had higher BMD than did nondrinkers at most sites tested. Fescaniks et al (28) also showed a linear increase in spine density over increasing categories of alcohol intake in postmenopausal women.

In the present study, we examined the effect of alcohol intake on BMD at baseline in elderly women recruited for a multicenter osteoporotic longitudinal study (Sites Testing Osteoporosis Prevention/Intervention; STOP/IT). In addition, we explored the possible mechanism of the effect of alcohol consumption by studying the biochemical variables related to bone and mineral metabolism.


   SUBJECTS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
The cross-sectional data presented here were derived from the baseline information collected at the Omaha site for 489 women aged 65–77 y who entered STOP/IT. All subjects were volunteers who responded to advertisements in local newspapers or to a mass mailing of letters inviting them to participate in a 3-y study. The recruitment and enrollment period was from November 1992 to February 1994. The subjects included 472 white women, 11 black women, 4 Hispanic women, 1 Asian woman, and 1 woman of mixed race. Subjects were excluded if they were taking medications or had diseases known to influence calcium or phosphorus metabolism. Data for 43 women taking thiazide diuretics and 1 woman with suspected Paget disease were excluded from the analysis. All subjects had normal liver and kidney function for entry into the study. They were free living and had a normal score for activities of daily living. The protocol was approved by the Creighton University Institutional Review Board.

Dietary intake, alcohol consumption, and smoking history
Dietary intake data were collected with use of 7-d food diaries. Plastic food models (NASCO, Fort Artinson, WI) were used to help participants better estimate the quantities consumed. Average daily calcium, vitamin D, and caffeine intakes were calculated by using FOOD PROCESSOR II PLUS (version 5.1; Esha Research, Salem, OR).

The information on alcohol consumption and smoking history was obtained by a self-administered questionnaire. The information on frequency of smoking (ie, number of cigarettes/wk) and the quantity of beer, wine, and mixed drinks (or undiluted spirits) consumed per week was obtained. Total alcohol consumption was computed by multiplying the average amounts of actual alcohol content in the beer, wine, and mixed drinks by the amount drunk with use of the following conversion formula (27):



Alcohol intake (in g/wk) was calculated for each subject by using an equivalence of 30 mL (1 oz) to 28.57 g alcohol.

On the basis of alcohol intake, the subjects were subdivided into alcohol drinkers and nondrinkers. Further, on the basis of the quantity of alcohol consumed, they were divided into 5 categories: nondrinkers, <=28.6 g/wk, >28.6 to <=57.2 g/wk, >57.2 to <=142.9 g/wk, and >142.9 g/wk. Reproductive history, present use of medications, and use of vitamin and mineral supplements were also assessed by a questionnaire. The information on past estrogen use and history of fractures was also obtained from the subjects.

Calcium absorption test
Calcium absorption was measured in a fasting state by oral administration of 18.5 x 104 Bq (5 µCi) 45Ca (Amersham, Arlington Heights, IL) in 100 mg CaCl2 carrier given in a total volume of 250 mL distilled water (29). A blood sample was collected 2 h after the oral dose. 45Ca activity was counted in 2 mL serum with a 1900 CA Tricarb Liquid scintillation analyzer (Packard Instrument, Meriden, CT). A parallel standard taken from the patient's dose before ingestion was counted at the same time as the sample. Calcium absorption was expressed as percentage of the actual dose/L blood (% AD/L) and corrected for body weight.

Biochemical analysis
Fasting blood and spot urine samples were collected before the calcium absorption test; a 24-h urine sample was also obtained from the subjects. Blood specimens were allowed to clot and were then centrifuged at 2056 x g for 15 min at 4°C to separate serum. All samples were stored frozen at –70°C until analyzed.

Serum and urine chemistry measurements
All serum and urine measurements were made with fresh samples. Serum ionized calcium and total calcium and creatinine in serum and urine samples (both spot and 24-h) were determined by using automated procedures (Nova Nucleus Chemistry Analyzer, Waltham, MA). Serum albumin, alanine aminotransferase (ALT), and alkaline phosphatase were measured by using automated procedures (Technicon SMAC Analyzer; Technicon Corp, Tarrytown, NY).

Serum calciotropic hormones
Serum 25-hydroxyvitamin D [calcidiol, or 25(OH)D] was measured with use of a competitive protein binding assay (30) after extraction and purification of serum on Sep-Pak cartridges (Waters Associates, Milford, MA) (31). The limit of detection was 12.5 mmol/L (5 µg/L) and the interassay variation was 5%. Serum 1,25-dihydroxyvitamin D [calcitriol, or 1,25(OH)2D] was measured with a nonequilibrium radioreceptor assay (Incstar Corp, Stillwater, MN) by using calf thymus receptor. The samples were extracted and purified before assay on nonpolar C18OH octadecyl silanol silica cartridges (32, 33). The limit of detection for the assay was 12 pmol/L (5 ng/L) and the interassay variation was 10%. Allegro immunoradiometric assay (Nichols Institute, San Juan Capistrano, CA) was used to measure serum intact PTH (iPTH) (34). The limit of detection for the assay was 1 ng/L (1 pg/mL) and the interassay variation was 5%.

Bone markers
Serum osteocalcin was measured by using radioimmunoassay (Incstar Corp). The limit of detection for the assay was 0.78 µg/L (0.78 ng/mL) and the interassay variation was 5%. Urine collagen crosslinks were measured by enzyme-linked immunosorbent assay (Osteomark International, Seattle) as N-telopeptides, a specific marker for bone type I collagen [expressed as nmol bone collagen equivalents (BCE)/mmol of creatinine].

Bone mineral density
BMD at hip (femoral neck, trochanter, and Ward's triangle), whole body, lumbar spine (vertebrae 1–2), and midradius was measured by dual-energy X-ray absorptiometry (model DPX-L; Lunar Corp, Madison, WI) by using standardized protocols for uniform subjects positioning, scan mode, and scan analysis. Hip and spine scans were performed in duplicate and the average value computed was used for the analysis. Of all the hip measurements, only the femoral neck BMD is reported because measurements at all the sites of hip showed a similar trend.

Statistical analysis
Data were analyzed with SPSS for WINDOWS (version 8.0; SPSS Inc, Chicago). BMD measurements of nondrinkers and drinkers were compared by analysis of covariance (ANCOVA) after adjustment for smoking status, past estrogen use, and other significantly correlated covariates identified by correlation analysis. A similar analysis was done between nondrinkers and consumers of various categories of alcohol intake. We used a Bonferroni multiple comparison test adjusted only for comparisons of interest (ie, the 4 subgroups of alcohol compared with nondrinkers) to determine post hoc significance between the various categories of alcohol intake. Measurements of calcitropic hormones, bone markers, and serum chemistry were analyzed similarly.

Pearson's correlation coefficients were calculated to determine whether the BMD measurements at various sites, calcitropic hormones, bone markers, and serum chemistry measurements were related to age, height, weight, age at menopause, dietary calcium, protein, vitamin D, and caffeine intakes. Covariates were considered significant if P was <0.05. Of all the covariates, weight was significantly correlated with most of the variables, whereas varied results were obtained for the other covariates. For each dependent variable in the ANCOVA, only significant (P < 0.05) covariates were included in the model. The data are presented as adjusted means and SEMs.

Of the total 445 subjects considered for the analysis, 88 had no information available for age at menopause. Years since menopause correlated significantly only with BMD measurements at spine and total body. Additional analysis that included years since menopause as a covariate for BMD measurements at spine and total body did not significantly affect the direction of the differences. Therefore, the results of BMD measurements for spine and total body, without correction for years since menopause, are presented.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Characteristics of the study population
A comparison of the characteristics of the study population between nondrinkers and between nondrinkers and subjects in the different categories of alcohol intake are shown in Table 1Go. The drinkers and nondrinkers were not significantly different with respect to age, height, and dietary calcium, vitamin D, protein, and energy intakes. Compared with the nondrinkers, the drinkers weighed significantly less and had significantly higher caffeine intakes. When compared by the amount of alcohol intake, drinkers with an alcohol intake of >57.2 to <=142.9 g/wk had significantly lower body weights than did nondrinkers. Although caffeine intake was marginally higher in all categories of drinkers than in nondrinkers, the values were not significantly different. The mean (±SEM) age at menopause was also significantly higher in drinkers (49.2 ± 0.79 y) than in nondrinkers (47.4 ± 0.42 y). When consumers of different categories of alcohol intake were compared with nondrinkers, none of them were significantly different from nondrinkers with regard to the age at menopause. Subjects in all the categories of alcohol intake were also not significantly different from nondrinkers with regard to age, height, or dietary calcium, vitamin D, protein, and energy intakes; 11.5% of nondrinkers and 18.2% of drinkers were current smokers. The percentage of current smokers in the alcohol intake categories of >57.2 to<=142.9 and >142.9 g/wk was higher: 23% and 30% of women in these categories, respectively, were current smokers. Eighteen percent of both alcohol drinkers and nondrinkers gave a history of estrogen use of >1 y. The distribution of percentage of past estrogen users was not significantly different between various categories of alcohol intake. Forty-seven percent of nondrinkers and 48% of drinkers had a history of fractures. The rate of history of fractures of consumers of various categories of alcohol intake was not significantly different from that of nondrinkers (nondrinkers, 47.3%; <=28.6 g/wk, 44.3%; >28.6 to >=57.2 g/wk, 51.5%; >57.2 to <=142.9 g/wk, 42.3%; and >142.9 g/wk, 55%; Pearson's chi-square, P < 0.87).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Characteristics of the study population1
 
Bone mineral density
The adjusted mean BMDs at lumbar spine (1.047 ± 0.020 compared with 0.951 ± 0.016 g/cm2, P < 0.000, 10% difference), total body (1.029 ± 0.011 compared with 0.986 ± 0.008 g/cm2, P < 0.001, 4.4% difference), and midradius (0.706 ± 0.013 compared with 0.666 ± 0.010 g/cm2, P < 0.014, 6% difference) were significantly higher in drinkers than in nondrinkers. BMD at the femoral neck (0.776 ± 0.011 compared with 0.756 ± 0.008 g/cm2, P < 0.141) also tended to be higher (2.6%) in drinkers than in nondrinkers. Adjusted mean BMDs at lumbar spine, femoral neck, total body, and midradius according to the category of alcohol intake are presented in Figure 1Go. When compared by the amount of alcohol intake, subjects in all categories of alcohol intake had higher BMDs than did nondrinkers at lumbar spine, total body, and midradius, though not significantly so at all levels. Of the various categories of alcohol intake, women with an intake of >28.6 to <=57.2 g/wk had the highest lumbar spine, total body, and midradius BMD compared with nondrinkers; the differences (all significant) were 16%, 12%, and 14%, respectively, between the 2 groups. Even at the femoral neck, this group of women tended to have higher BMD (6%), but this difference was not significant. Consumption of >57.2 to <=142.9 and >142.9 g/wk also tended to increase the BMD at all the sites measured. However, only lumbar spine density (15%) and total body density (5.5%) of subjects in the category of >142.9 g/wk were significantly higher than that of nondrinkers.



View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 1. . Adjusted mean (±SEM) lumbar spine, femoral neck, total body, and midradius bone mineral densities (BMDs) for various alcohol intakes, compared by analysis of covariance adjusted for smoking, past estrogen use, and other significant covariates (spine BMD was adjusted for smoking status, past estrogen use, height, and weight; femoral neck BMD was adjusted for smoking status, past estrogen use, age, height, and weight; total body BMD was adjusted for smoking status, past estrogen use, height, weight, dietary calcium, and dietary caffeine intakes; midradius BMD was adjusted for smoking status, past estrogen use, age, weight, dietary calcium, and dietary caffeine intakes). *, **Significantly different from nondrinkers (Bonferroni multiple-comparison test): *P < 0.05, **P < 0.01.

 
Biochemical variables
Calcium absorption and serum variables
Data on calcium absorption, serum variables, and calcitropic hormones of drinkers, nondrinkers, and subjects in various categories of alcohol intake are given in Table 2Go. Calcium absorption was not significantly different between drinkers and nondrinkers, and the amount of alcohol consumed had no significant effect on calcium absorption. Serum calcium, ionized calcium, phosphorus, alkaline phosphatase, and albumin of drinkers were also not significantly different from those of nondrinkers. Serum ionized calcium was significantly higher in women with an alcohol intake of >28.6 to <=57.2 g/wk than in nondrinkers, whereas in other categories of alcohol intake the values were not significantly different from those of nondrinkers. Serum calcium, phosphorus, alkaline phosphatase, and albumin were not significantly different between consumers of different categories of alcohol intake and nondrinkers, except for alkaline phosphatase, which was significantly higher in subjects with an alcohol intake <=28.6 g/wk than in nondrinkers. The liver enzyme ALT was not significantly different between the alcohol drinkers and the nondrinkers (0.5 ± 0.03 compared with 0.47 ± 0.01 µkat/L) and between the consumers of different categories of alcohol intake and the nondrinkers (nondrinkers, 0.47 ± 0.01; <=28.6 g/wk, 0.49 ± 0.03; >28.6 to <=57.2 g/wk, 0.45 ± 0.02; >57.2 to >=142.9 g/wk, 0.49 ± 0.03; and >142.9 g/wk, 0.54 ± 0.04 µkat/L).


View this table:
[in this window]
[in a new window]
  		TABLE 2. Biochemical variables in drinkers, nondrinkers, and consumers of different categories of alcohol intake1
 
Calcitropic hormones
Serum 25(OH)D (Table 2Go) tended to be slightly lower in alcohol consumers than in nondrinkers, but this difference was not significant. On the other hand, serum PTH was significantly lower in alcohol drinkers than in nondrinkers.

When the subjects were categorized into different levels of alcohol intake, serum 25(OH)D tended to be lower in subjects with an alcohol intake of >57.2 to <=142.9 g/wk than in nondrinkers (Table 2Go). Serum 25(OH)D in other categories of alcohol intake was not significantly different from that of nondrinkers. Women with alcohol intakes of >28.6 to <=57.2, >57.2 to <=142.9, and >142.9 g/wk had lower serum PTH concentrations than did nondrinkers, but only in women with an alcohol intake >28.6 to <=57.2 g/wk were the values significantly lower (Figure 2Go). Serum 1,25(OH)2D concentrations were not significantly different between drinkers and nondrinkers (Table 2Go) and the amount of alcohol consumed did not significantly influence the serum 1,25(OH)2D concentrations.



View larger version (19K):
[in this window]
[in a new window]
  		FIGURE 2. . Adjusted mean (±SEM) bone marker (osteocalcin and N-telopeptide) and serum parathyroid hormone (PTH) data for alcohol intakes, compared by analysis of covariance adjusted for smoking status, past estrogen use, and other significant covariates (serum osteocalcin and urine N-telopeptides were adjusted for smoking status, past estrogen use, and body weight; serum PTH was adjusted for smoking status, past estrogen use, body weight, dietary calcium, and vitamin D intakes). *Significantly different from nondrinkers, P < 0.05 (Bonferroni multiple-comparison test). NTX:Cr, ratio of urinary cross-linked N-telopeptides of type 1 collagen to creatinine.

 
Bone markers
Serum osteocalcin, a bone formation marker, was significantly lower in alcohol drinkers than in nondrinkers (3.43 ± 0.160 compared with 4.14 ± 0.126 µg/L, P < 0.001). The bone resorption marker ratio of urinary cross-linked N-telopeptides of type 1 collagen to creatinine (NTX:Cr) was not significantly different between drinkers and nondrinkers (49.14 ± 3.45 compared with 54.35 ± 2.70 nmol BCE/nmol Cr). The bone marker data for various categories of alcohol intake are shown in Figure 2Go. Women with an alcohol intake of >28.6 to <=57.2 g/wk or an intake of >57.2 to <=142.9 g/wk had significantly lower serum osteocalcin concentrations (31% and 33%, respectively) than did nondrinkers. Women in alcohol intake categories of >28.6 to <=57.2, >57.2 to <=142.9, and >142.9 g/wk had lower NTX:Cr (38%, 27%, and 19%, respectively) than did nondrinkers, although not significantly so.

Correlations were run between bone markers, serum PTH, and BMD for the entire study population. A significant positive correlation (although not a very strong one) was observed between PTH and bone remodeling markers (PTH and serum osteocalcin, r = 0.211, P < 0.001; PTH and NTX:Cr, r = 0.11, P < 0.05). There were significant negative correlations (albeit weak) between bone remodeling markers and BMD (total body BMD and serum osteocalcin, r = -0.30, P < 0.001; total body BMD and NTX:Cr, r = -0.32, P < 0.001; spine BMD and serum osteocalcin, r = -0.141, P < 0.01; spine BMD and NTX:Cr, r = -0.140, P < 0.01).

The fasting ratio of urinary calcium to creatinine (Ca:Cr) (Table 2Go) was not significantly different between drinkers and nondrinkers. However, women with an alcohol intake of >28.6 to <=57.2 g/wk had significantly higher excretion of calcium in urine than did nondrinkers (Table 2Go). Fasting Ca:Cr in other categories of alcohol intake was not significantly different from that of nondrinkers.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The results presented in this article provide further evidence for a positive association between BMD and moderate alcohol consumption in elderly postmenopausal women, which is consistent with other published reports (22–25). In addition, we also present evidence that the effect of alcohol can be attributed to reduced bone remodeling.

Laitinen et al (22) first reported a positive correlation between alcohol intake and BMD, with a 12%, 15%, and 9% increase at lumbar spine, Ward's triangle, and femoral neck, respectively, in alcohol drinkers; spine and Ward's triangle values were significant. Feskanich et al (28) observed that women who consumed >=75 g alcohol/wk had significantly higher lumbar spine BMD (12%) than did nondrinking women. They also observed a linear increase in spinal BMD over increasing alcohol intakes. However, a similar effect was not found at femoral neck and total hip. Holbrook and Barrett-Connor (26), in a prospective study of men and women, observed that alcohol consumption was associated with an increase in BMD. They reported significant increases in BMD at femur in men and at spine and midradius in women with increasing alcohol intakes (10% increase with alcohol intake of 120 g/wk). In the Framingham study, Felson et al (27) observed that women who drank >=200 g alcohol/wk had higher BMD than did those who drank <200 g. They reported 7.5%, 6%, and 4% higher spine, radius, and femoral neck BMD, respectively, in alcohol drinkers; only spine and radius BMD changes were significant. These authors made similar observations in men with high alcohol intakes, although the results were not significant.

In the present study, we observed a significant positive effect of alcohol consumption >28.6 g/wk, which is lower than that reported by earlier researchers. Maximum benefit of alcohol consumption was noted at an intake of >28.6 to <=57.2 g/wk. Intakes of >57.2 to <=142.9 and >142.9 g/wk also increased BMD but the effect was less than that seen with an intake of >28.6 to <=57.2 g/wk. As observed by others, the effect of alcohol was seen primarily at the lumbar spine (ranging from 7% to 16% for various alcohol intakes). In addition, in our study, increasing alcohol intakes increased BMD significantly at the midradius (8–14% for various alcohol intakes) and total body (5–12% at different alcohol intakes). Although femur density was increased by alcohol intake, the effect was not significant, as seen by earlier researchers.

The higher BMD seen in alcohol drinkers in our study could be due mainly to reduction in bone remodeling, as evidenced by the decrease in bone resorption markers, NTX:Cr (19–38% for various alcohol intake categories) and serum osteocalcin (22–31% for various alcohol intake categories). This is the first study that provides direct evidence of decreased bone remodeling markers with moderate alcohol consumption in postmenopausal elderly women.

Although serum osteocalcin is secreted by osteoblasts and is a marker of bone formation, it correlates highly with resorption because formation and resorption are coupled. Serum osteocalcin is increased in diseases with accelerated bone turnover rate (35, 36). In fact, in our study we observed a significant positive correlation between serum osteocalcin and urinary N-telopeptides.

We observed decreased serum PTH concentrations with intakes of alcohol >28.6 g/wk, which could be a cause of the reduced bone resorption. Decreased secretion of PTH hormone was observed with short-term alcohol consumption (37). In addition, Diez et al (38) reported decreased PTH after adjustment for age and sex in 20 men and 6 women with daily intakes of >=150 g alcohol for >=8 y. In our study, we observed a significant positive correlation between serum PTH and bone markers. The bone markers were in turn negatively correlated with BMD. This further corroborates our notion that the reduced bone remodeling may be due to decreased PTH concentrations.

Other causes of increases in BMD with alcohol consumption that have been suggested are increased serum calcitonin concentrations and increased estrogen concentration. Alcohol is known to stimulate calcitonin production (13), which increases the vertebral BMD without much effect on femoral sites (39, 40). Alternatively, elevation of estrogen concentrations by moderate alcohol consumption may help protect the skeleton. Higher estrogen concentrations have been found in postmenopausal women who consume alcohol (41–43). Thus, the effect of alcohol could also be explained by hormonal factors. The age at menopause in our study subjects was significantly higher in alcohol drinkers than in nondrinkers. Early menopause in women is associated with quantitatively higher bone loss than in women with late-onset menopause (44). It could be argued that the late menopause in alcohol consumers is one of the reasons for the higher BMD observed in these women. However, even after adjustment for age at menopause, alcohol consumption was associated with higher BMD, suggesting that the effect of alcohol was not due to delayed menopause.

In the present study, serum 25(OH)D was found to be marginally lower in subjects consuming >57.2 to <=142.9 g alcohol/wk. However, serum 1,25(OH)2D concentrations remained normal in these subjects. A decreased concentration of total 25(OH)D with normal free 25(OH)D has been reported in chronic alcoholism (45). The effect of alcohol intakes of >28.6 to <=57.2 g/wk, which is a moderate range, on calcitropic hormones tends to be similar to that seen in chronic alcoholism, although it is marginal. The reason for this observation is not clear. To our knowledge there are no reports of the effect of moderate alcohol consumption on calcitropic hormones in postmenopausal women.

In conclusion, we report a positive association between alcohol consumption and BMD. We also provide substantial evidence indicating that the increase in BMD by alcohol in our elderly population was due mainly to a decrease in bone remodeling. The decreased remodeling may have been due to lowered serum PTH concentrations or may have been mediated through hormonal effects such as higher serum calcitonin concentrations or estrogen concentrations. Although mild to moderate alcohol intake has a protective effect on bone, these results should be viewed with caution because alcohol abuse has apparent untoward effects on bone mineral metabolism.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Saville PD. Changes in bone mass with age and alcoholism. J Bone Joint Surg 1965;47-A:492–9.[Abstract/Free Full Text]
  2. Saville PD. Alcohol-related skeletal disorders. Ann N Y Acad Sci 1975;252:287–91.[Medline]
  3. Spencer H, Rubio N, Rubio E, Indreika M, Seitam A. Chronic alcoholism. Frequently overlooked cause of osteoporosis in men. Am J Med 1986;80:393–7.[Medline]
  4. Laitinen K, Valimaki M. Alcohol and bone. Calcif Tissue Int 1991; 49:S70–3.
  5. Bikle DD. Alcohol-induced bone disease. World Rev Nutr Diet 1993;73:53–73.[Medline]
  6. Sampson HW. Alcohol, osteoporosis and bone regulating hormones. Alcohol Clin Exp Res 1997;21:400–3.[Medline]
  7. Sampson HW, Chaffin C, Lange J, Defee B II. Alcohol consumption by young actively growing rats: a histomorphometric study of cancellous bone. Alcohol Clin Exp Res 1997;21:352–9.[Medline]
  8. Klein RF, Fausti KA, Carlos AS. Ethanol inhibits human osteoblastic cell proliferation. Alcohol Clin Exp Res 1996;20:572–8.[Medline]
  9. Crilly RG, Anderson C, Hogan D, Delaquerriere-Richardson L. Bone histomorphometry, bone mass and related parmeters in alcoholic males. Calcif Tiss Int 1988;43:269–76.[Medline]
  10. Schnitzler CM, Solomon L. Bone changes after alcohol abuse. S Afr Med J 1984;66:730–4.[Medline]
  11. Bikle DD, Genant HK, Cann C, Recker RR, Halloran BP, Strewler GJ. Bone disease in alcohol abuse. Ann Intern Med 1985;103:42–8.
  12. Feitelberg S, Epstein S, Ismail F, D'Amanda C. Deranged bone mineral metabolism in chronic alcoholism. Metabolism 1987;36:322–6.[Medline]
  13. Rico H. Alcohol and bone disease. Alcohol Alcohol 1990;25:345–52.[Abstract/Free Full Text]
  14. Shaw CK. An epidemiologic study of osteoporosis in Taiwan. Ann Epidemiol 1993;3:264–71.[Medline]
  15. Elders PJ, Netelenbos JC, Lips P, et al. Perimenopausal bone mass and risk factors. Bone Miner 1989;7:289–99.[Medline]
  16. Slemenda CW, Hui SL, Longcope C, Wellman H, Johnston CC Jr. Predictors of bone mass in premenopausal women: a prospective study of clinical data using photon absorptiometry. Ann Intern Med 1990;112:96–101.
  17. Cauley JA, Gutai JP, Kuller LH, et al. Endogenous estrogen levels and calcium intakes in postmenopausal women. Relationships with cortical bone measures. JAMA 1988;260:3150–5.[Abstract]
  18. Bauer DC, Browner WS, Cauley JA, et al. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fracture Research Group. Ann Intern Med 1993;118:657–65.[Abstract/Free Full Text]
  19. Stevenson JC, Lees B, Devenport M, Cust MP, Ganger KF. Determinants of bone density in normal women: risk factors for future osteoporosis? BMJ 1989;298:924–8.
  20. Hall ML, Heavens J, Cullum ID, Ell PJ. The range of bone density in normal British women. Br J Radiol 1990;63:266–9.[Abstract]
  21. Tuppurainen M, Kroger H, Honkanen R, et al. Risks of perimenopausal fractures—a prospective population based study. Acta Obstet Gynecol Scand 1995;74:624–8.[Medline]
  22. Laitinen K, Valimaki M, Keto P. Bone mineral density measured by dual-energy x-ray absorptiometry in healthy Finnish women. Calcif Tissue Int 1991;48:224–31.[Medline]
  23. Angus RM, Sambrook PN, Pocock NA. Dietary intake and bone mineral density. Bone Miner 1988;4:265–77.[Medline]
  24. Hansen MA, Overgaard K, Riis BJ, Christiansen C. Potential risk factors for development of postmenopausal osteoporosis—examined over a 12-year period. Osteoporos Int 1991;1:95–102.[Medline]
  25. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 1996;144: 255–63.[Abstract/Free Full Text]
  26. Holbrook TL, Barrett-Connor E. A prospective study of alcohol consumption and bone mineral density. BMJ 1993;306:1506–9.
  27. Felson DT, Zhang Y, Hannan MT, Kannel WB, Kiel DP. Alcohol intake and bone mineral density in elderly men and women. The Framingham Study. Am J Epidemiol 1995;142:485–92.[Abstract/Free Full Text]
  28. Feskanich D, Korrick SA, Greenspan SL, Rosen HN, Colditz GA. Moderate alcohol consumption and bone density among postmenopausal women. J Womens Health 1999;8:65–73.[Medline]
  29. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, Deluca HF. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J Clin Invest 1979;64: 729–36.
  30. Haddad JG, Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 1971;33:992–5.[Medline]
  31. Reinhardt TA, Horst RL. Simplified assays for the determination of 25OHD, 24,25(OH)2D and 1,25(OH)2D. In: Norman AW, Schaefer K, Grigoleit HG, Herratt DV, eds. Vitamin D, molecular, cellular and clinical endocrinology. New York: Walter de Gruyter, 1988:720–6.
  32. Reinhardt TA, Horst RL, Orf JW, Hollis BW. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 1984;58:91–8.[Abstract]
  33. Hollis BW. Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clin Chem 1986;32:2060–3.[Abstract/Free Full Text]
  34. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. Highly sensitive two-site immunoradiometric asssay of parthyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987;33:1364–7.[Abstract/Free Full Text]
  35. Gundberg CM, Lian JB, Gallop PM, Stienberg JJ. Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease. J Clin Endocrinol Metab 1983;57:1221–5.[Abstract]
  36. Ezzat S, Melmed S, Endres D, Eyre DR, Signer FR. Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 1993;76:1452–7.[Abstract]
  37. Laitinen K, Lamberg-Allardt C, Tunninen R, et al. Transient hypoparathyroidism during acute alcohol intoxication. N Engl J Med 1991;324:721–7.[Abstract]
  38. Diez A, Puig J, Serrano S, et al. Alcohol-induced bone disease in the absence of severe chronic liver damage. J Bone Miner Res 1994; 9:825–31.[Medline]
  39. Civitelli R, Gonnelli S, Zacchei F, et al. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 1988;82:1268–74.
  40. Ellerington MC, Hillard TC, Whitcroft SI, et al. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporois. Calcif Tissue Int 1996;59:6–11.[Medline]
  41. Gavaler JS, Van Thiel DH. The association between moderate alcoholic beverage consumption and serum estradiol and testosterone levels in normal post menopausal women: relationship to the literature. Alcohol Clin Exp Res 1991;16:87–92.
  42. Katsouyanni K, Boyle P, Trichopoulos D. Diet and urine estrogens among postmenopausal women. Oncology 1991;48:490–4.[Medline]
  43. Hankinson SE, Willett WC, Manson JE, et al. Alcohol, height and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995;87:1297–302.[Abstract/Free Full Text]
  44. Pouilles JM, Tremollieres F, Bonneu M, Ribot C. Influence of early age at menopause on vertebral bone mass. J Bone Miner Res 1994; 9:311–5.[Medline]
  45. Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest 1986;78:748–52.
Received for publication January 25, 2000. Accepted for publication May 30, 2000.




This article has been cited by other articles:


Home page
 Alcohol AlcoholHome page
J.-P. KAUKONEN, I. NURMI-LUTHJE, P. LUTHJE, H. NABOULSI, S. TANNINEN, M. KATAJA, M.-L. KALLIO, and M. LEPPILAMPI
ACUTE ALCOHOL USE AMONG PATIENTS WITH ACUTE HIP FRACTURES: A DESCRIPTIVE INCIDENCE STUDY IN SOUTHEASTERN FINLAND
Alcohol Alcohol., May 1, 2006; 41(3): 345 - 348.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
F M K Williams, L F Cherkas, T D Spector, and A J MacGregor
The effect of moderate alcohol consumption on bone mineral density: a study of female twins
Ann Rheum Dis, February 1, 2005; 64(2): 309 - 310.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
K. Alagiakrishnan, A. Juby, D. Hanley, W. Tymchak, and A. Sclater
Role of Vascular Factors in Osteoporosis
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M362 - 366.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. A. M. Dhonukshe-Rutten, M. Lips, N. de Jong, M. J. M. Chin A Paw, G. J. Hiddink, M. van Dusseldorp, L. C. P. G. M. de Groot, and W. A. van Staveren
Vitamin B-12 Status Is Associated with Bone Mineral Content and Bone Mineral Density in Frail Elderly Women but Not in Men
J. Nutr., March 1, 2003; 133(3): 801 - 807.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
J. Z. Ilich, R. A. Brownbill, L. Tamborini, and Z. Crncevic-Orlic
To Drink or Not to Drink: How Are Alcohol, Caffeine and Past Smoking Related to Bone Mineral Density in Elderly Women?
J. Am. Coll. Nutr., December 1, 2002; 21(6): 536 - 544.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. Mukherjee and M. F Sorrell
Effects of alcohol consumption on bone metabolism in elderly women
Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1073 - 1073.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rapuri, P. B
Right arrow Articles by Ryschon, K. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rapuri, P. B
Right arrow Articles by Ryschon, K. L
Agricola
Right arrow Articles by Rapuri, P. B
Right arrow Articles by Ryschon, K. L

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS